pargyline has been researched along with Cardiovascular Diseases in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clorgyline and pargyline were used as inhibitors of monoamine oxidase (MAO) A and B, respectively." | 1.27 | Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors. ( Cox, LR; Grossman, SL; Ramos, K, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramos, K | 1 |
| Grossman, SL | 1 |
| Cox, LR | 1 |
1 other study available for pargyline and Cardiovascular Diseases
| Article | Year |
|---|---|
Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
Topics: Acrolein; Aldehydes; Allylamine; Amines; Animals; Benzylamine Oxidase; Cardiovascular Diseases; Cell | 1988 |